These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1207545)

  • 21. [Triaminopteridine in the therapy of myasthenia gravis].
    Mansoldo G; Battocchia A; De Candia O
    Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of myasthenia. II.
    Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
    [No Abstract]   [Full Text] [Related]  

  • 23. Lcal administration of 1 per cent Ubretid in the handling of glaucoma, myasthenia gravis and esotropia.
    Ishikawa S; Tsukahara S; Sato Y
    Ophthalmologica; 1969; 159(4):339-62. PubMed ID: 5393688
    [No Abstract]   [Full Text] [Related]  

  • 24. Case report: A young man with progressive weakness, double vision and breathlessness.
    Benjamin LA; Chipolombwe J; Domargard K
    Malawi Med J; 2011 Sep; 23(3):94-5. PubMed ID: 23448005
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.
    Dandona P; Corkan EJ; Sladen GE
    Postgrad Med J; 1977 Jun; 53(620):321-4. PubMed ID: 887530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis: case report and analysis.
    Hanson CJ
    J Am Osteopath Assoc; 1982 Feb; 81(6):378-81. PubMed ID: 7068459
    [No Abstract]   [Full Text] [Related]  

  • 27. Myasthenia gravis mimicking unilateral vocal fold paralysis at presentation.
    Hartl DM; Leboulleux S; Klap P; Schlumberger M
    J Laryngol Otol; 2007 Feb; 121(2):174-8. PubMed ID: 17112394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of myasthenia gravis].
    Igata A
    Naika; 1970 Apr; 25(4):676-82. PubMed ID: 5423420
    [No Abstract]   [Full Text] [Related]  

  • 29. The management of myasthenia gravis.
    Preswick G
    Acta Med Philipp; 1966; 2(3):157-8. PubMed ID: 5915027
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of myasthenia gravis.
    Lazar A
    J Assoc Physicians India; 1991 Aug; 39(8):655. PubMed ID: 1814893
    [No Abstract]   [Full Text] [Related]  

  • 31. Recovery from myasthenic crisis after use of IVIG therapy.
    Jain K; Passi GR; Rajguru M; Athle S; Gandhi DM
    Indian Pediatr; 1998 Sep; 35(9):901-3. PubMed ID: 10216601
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis.
    Punga AR; Sawada M; Stålberg EV
    Muscle Nerve; 2008 Mar; 37(3):300-7. PubMed ID: 18069667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis. Emergency treatment.
    Kennedy WR
    Minn Med; 1968 Sep; 51(9):1291-3. PubMed ID: 5679230
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of myasthenia gravis].
    Aarli JA; Halvorsen JF; Varhaug JE; Jacobsen H
    Tidsskr Nor Laegeforen; 1982 Feb; 102(5):301-3. PubMed ID: 7157277
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
    Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
    Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):726-8. PubMed ID: 4325239
    [No Abstract]   [Full Text] [Related]  

  • 38. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
    Brostoff JM; Dahdaleh D; Birns J
    Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacological basis for the treatment of myasthenia gravis.
    Flacke W
    Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.